The APAC tissue diagnostics market was worth USD 0.89 billion in 2021 and is estimated to be growing at a CAGR of 8.84%, to reach USD 1.36 billion by 2026.
Tissue-based diagnostic tests are performed to screen, diagnose, and monitor cancer patients' response to therapy. The tissue diagnostics market's scope includes major technologies like In Situ hybridization, IHC, digital pathology and workflow, special staining, and products such as instruments and consumables to determine medical information to diagnose diseases or conditions.
Tissue Diagnostics market expansion is expected to be driven by rising cancer prevalence, rising healthcare costs, and increased funding for research activities aimed at creating cancer treatments.
Other factors such as increased lifestyle changes, rising food and tobacco consumption, alcohol consumption, and an increase in prevalent lifestyle problems are expected to boost the market growth.
The tissue-based diagnosis method aids in determining the cause and effect of a patient's illness. The number of cancer incidents is increasing each year as a result of people's unhealthy lifestyles, boosting the demand for tissue-based diagnosis.
A cancer diagnosis and therapy at an early stage will increase the chances of survival. Therefore, the Diagnostics market will develop significantly as labs are forced to improve diagnosis efficiency to ensure patient health security.
The tissue diagnosis technique is one of the highest achievements in cancer diagnosis, and it is the market's most important driver.
On the other hand, the growing number of government programs raised awareness about the need for early cancer detection to propel the tissue Diagnostics market forward.
Furthermore, factors such as increased investments in research and development of new technologies, the emergence of efficient and accurate products, growing demand for personalized medicines, and untapped market potential due to a lack of efficient Diagnostics tests for non-small lung cancer detection are expected to provide lucrative opportunities for tissue Diagnostics market growth. Furthermore, the growing scale of healthcare institutes is expected to boost demand for the tissue diagnostics market.
However, The market growth is hampered by a small customer base for tissue Diagnostics, restricted budget constraints, and regulatory framework issues.
This research report on the APAC tissue diagnostics market has been segmented and sub-segmented into the following categories:
By Product Type:
By Disease:
By Application:
By End-user:
By Country:
The APAC tissue diagnostics market is anticipated to witness significant growth during the forecast period. The market growth is attributed to increased healthcare spending, growing infrastructure for cancer Diagnostics, and government assistance. Moreover, increased attention of government and private sectors in developing nations such as China. Japan, India, and other, the Asia Pacific market is expected to grow significantly during the forecast period. China, India, Japan, Korea, Indonesia, and Australia, according to the World Health Organization (WHO), are the primary regions with the highest number of cancer patients. As a result, Western medical devices companies are interested in expanding their operations in the Asia Pacific tissue Diagnostics market and medical devices business. Every year, an average of 70 million newly diagnosed patients are documented in the Asia Pacific region, according to the Cancer Index Organization. As the population of senior people grows, so does the risk of cancer, which means there is a lot of growth in the diagnosis market. The Southeast Asian countries are rapidly developing economically and investing heavily in the healthcare sector.
China accounted for the largest share of the Tissue Diagnostics market. The market growth is driven by the technological advancements in the healthcare sector, the presence of key market players, and favorable reimbursement policies.
On the other hand, the Indian Tissue Diagnostics market is one of the fastest-growing countries. The factors such as improving the rising healthcare sector, active, supportive government policies, and growing awareness are fuelling the market growth.
KEY MARKET PARTICIPANTS:
Some of the noteworthy companies dominating the APAC tissue diagnostics market are F. Hoffmann-La Roche AG, Sigma-Aldrich Co. LLC, Abbott Laboratories, Agilent Technologies, BioGenex, Danaher Corporation, Cell Signaling Technology, and Ventana Medical Systems.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product type
5.1.1 Introduction
5.1.2 Instruments
5.1.2.1 Microscope
5.1.2.2 Non-contact Handheld IR Thermometer
5.1.2.3 Haemocytometer
5.1.2.4 NMR Tube
5.1.2.5 Others
5.1.3 Consumables
5.1.3.1 Reagent kits
5.1.3.2 Others
5.1.4 Y-o-Y Growth Analysis, By Product type
5.1.5 Market Attractiveness Analysis, By Product type
5.1.6 Market Share Analysis, By Product type
5.2 Disease
5.2.1 Introduction
5.2.2 Lung cancer
5.2.3 Lymphoma
5.2.4 Pancreatic cancer
5.2.5 Breast cancer
5.2.6 Others
5.2.7 Y-o-Y Growth Analysis, By Disease
5.2.8 Market Attractiveness Analysis, By Disease
5.2.9 Market Share Analysis, By Disease
5.3 Application
5.3.1 Introduction
5.3.2 Hematoxylin and Eosin
5.3.3 Immunohistochemistry
5.3.4 In Situ Hybridization
5.3.5 Y-o-Y Growth Analysis, By Application
5.3.6 Market Attractiveness Analysis, By Application
5.3.7 Market Share Analysis, By Application
5.4 End-user
5.4.1 Introduction
5.4.2 Hospitals
5.4.3 Diagnostic laboratories
5.4.4 Research Organizations
5.4.5 Contract Research Organizations
5.4.6 Biotechnology Companies
5.4.7 Y-o-Y Growth Analysis, By End-user
5.4.8 Market Attractiveness Analysis, By End-user
5.4.9 Market Share Analysis, By End-user
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product type
6.1.3.3 By Disease
6.1.3.4 By Application
6.1.3.5 By End-user
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product type
6.1.4.3 By disease
6.1.4.4 By Application
6.1.4.5 By End-user
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product type
6.1.5.3 By Disease
6.1.5.4 By Application
6.1.5.5 By End-user
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 F. Hoffmann-La Roche AG
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Sigma-Aldrich Co. LLC
8.3 Abbott Laboratories
8.4 Agilent Technologies
8.5 BioGenex
8.6 Danaher Corporation
8.7 Cell Signaling Technology
8.8 Ventana Medical Systems
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
11. Appendix
a) List of Tables
b) List of Figures
Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and also identify the regions that are still untapped
Segment-level analysis in terms of product type, application, disease and end-user along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economic, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis, and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies, and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Asia Pacific Tissue diagnostics Market, By Product type, From 2021 to 2026 (USD Billion)
Asia Pacific Instruments Market, By Region, From 2021 to 2026 (USD Billion)
Asia Pacific Consumables Market, By Region, From 2021 to 2026 (USD Billion)
Asia Pacific Tissue diagnostics Market, By Disease, From 2021 to 2026 (USD Billion)
Asia Pacific Lung cancer Market, By Region, From 2021 to 2026 (USD Billion)
Asia Pacific Lymphoma Market, By Region, From 2021 to 2026 (USD Billion)
Asia Pacific Pancreatic cancer Market, By Region, From 2021 to 2026 (USD Billion)
Asia Pacific Breast cancer Market, By Region, From 2021 to 2026 (USD Billion)
Asia Pacific Others Market, By Region, From 2021 to 2026 (USD Billion)
Asia Pacific Tissue diagnostics Market, By Application, From 2021 to 2026 (USD Billion)
Asia Pacific Hematoxylin and Eosin Market, By Region, From 2021 to 2026 (USD Billion)
Asia Pacific Immunohistochemistry Market, By Region, From 2021 to 2026 (USD Billion)
Asia Pacific In Situ Hybridization Market, By Region, From 2021 to 2026 (USD Billion)
Asia Pacific Tissue diagnostics Market, By End user, From 2021 to 2026 (USD Billion)
Asia Pacific Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
Asia Pacific Diagnostic laboratories Market, By Region, From 2021 to 2026 (USD Billion)
Asia Pacific Research Organizations Market, By Region, From 2021 to 2026 (USD Billion)
Asia Pacific Contract Research Organizations Market, By Region, From 2021 to 2026 (USD Billion)
Asia Pacific Biotechnology Companies Market, By Region, From 2021 to 2026 (USD Billion)
Japan Tissue diagnostics Market, By Product type, From 2021 to 2026 (USD Billion)
Japan Tissue diagnostics Market, By Disease, From 2021 to 2026 (USD Billion)
Japan Tissue diagnostics Market, By Application, From 2021 to 2026 (USD Billion)
Japan Tissue diagnostics Market, By End user, From 2021 to 2026 (USD Billion)
China Tissue diagnostics Market, By Product type, From 2021 to 2026 (USD Billion)
China Tissue diagnostics Market, By Disease, From 2021 to 2026 (USD Billion)
China Tissue diagnostics Market, By Application, From 2021 to 2026 (USD Billion)
China Tissue diagnostics Market, By End user, From 2021 to 2026 (USD Billion)
India Tissue diagnostics Market, By Product type, From 2021 to 2026 (USD Billion)
India Tissue diagnostics Market, By Disease, From 2021 to 2026 (USD Billion)
India Tissue diagnostics Market, By Application, From 2021 to 2026 (USD Billion)
India Tissue diagnostics Market, By End user, From 2021 to 2026 (USD Billion)
Australia Tissue diagnostics Market, By Product type, From 2021 to 2026 (USD Billion)
Australia Tissue diagnostics Market, By Disease, From 2021 to 2026 (USD Billion)
Australia Tissue diagnostics Market, By Application, From 2021 to 2026 (USD Billion)
Australia Tissue diagnostics Market, By End user, From 2021 to 2026 (USD Billion)
South Korea Tissue diagnostics Market, By Product type, From 2021 to 2026 (USD Billion)
South Korea Tissue diagnostics Market, By Disease, From 2021 to 2026 (USD Billion)
South Korea Tissue diagnostics Market, By Application, From 2021 to 2026 (USD Billion)
South Korea Tissue diagnostics Market, By End user, From 2021 to 2026 (USD Billion)
Asia Pacific Tissue diagnostics Market, By Instruments, From 2021 to 2026 (USD Billion)
Asia Pacific Microscope Market, By Region, From 2021 to 2026 (USD Billion)
Asia Pacific Non-contact Handheld IR Thermometer Market, By Region, From 2021 to 2026 (USD Billion)
Asia Pacific Haemocytometer Market, By Region, From 2021 to 2026 (USD Billion)
Asia Pacific NMR Tube Market, By Region, From 2021 to 2026 (USD Billion)
Asia Pacific Others Market, By Region, From 2021 to 2026 (USD Billion)
Japan Tissue diagnostics Market, By Instruments, From 2021 to 2026 (USD Billion)
China Tissue diagnostics Market, By Instruments, From 2021 to 2026 (USD Billion)
India Tissue diagnostics Market, By Instruments, From 2021 to 2026 (USD Billion)
Australia Tissue diagnostics Market, By Instruments, From 2021 to 2026 (USD Billion)
Related Reports
Apr 2021
